Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-28

Clinical Trial Update: Combination of Novel Therapies for CKD Comorbid Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a combination of novel therapies for chronic kidney disease with comorbid depression is currently recruiting (sponsor: Stony B…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TBD

Snippet

Sponsor: Stony Brook University | Conditions: Chronic Kidney Diseases, Major Depressive Disorder | Phase 2 | Status: RECRUITING